Does ABEMACICLIB Cause Malignant neoplasm progression? 890 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 890 reports of Malignant neoplasm progression have been filed in association with ABEMACICLIB (Verzenio). This represents 5.4% of all adverse event reports for ABEMACICLIB.
890
Reports of Malignant neoplasm progression with ABEMACICLIB
5.4%
of all ABEMACICLIB reports
152
Deaths
216
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ABEMACICLIB?
Of the 890 reports, 152 (17.1%) resulted in death, 216 (24.3%) required hospitalization, and 20 (2.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABEMACICLIB. However, 890 reports have been filed with the FAERS database.
What Other Side Effects Does ABEMACICLIB Cause?
Diarrhoea (4,988)
Fatigue (1,878)
Nausea (1,682)
Vomiting (943)
Decreased appetite (744)
Death (696)
Asthenia (678)
Drug ineffective (668)
White blood cell count decreased (566)
Anaemia (555)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ABEMACICLIB Alternatives Have Lower Malignant neoplasm progression Risk?
ABEMACICLIB vs ABILIFY
ABEMACICLIB vs ABIRATERONE
ABEMACICLIB vs ABIRATERONE\ABIRATERONE
ABEMACICLIB vs ABOBOTULINUMTOXINA
ABEMACICLIB vs ABRAXANE